MIFH
TAK icon

Migdal Insurance & Financial Holdings’s Takeda Pharmaceutical TAK Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,121
Closed -$42K – 689
2021
Q4 		$42K Sell
3,121
-4,378
-58% -$61.4K ﹤0.01% 479
2021
Q3 		$123K Buy
+7,499
New +$126K ﹤0.01% 336

Other funds holding TAK

PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Migdal Insurance & Financial Holdings's TAK Position: Q1 2022 in Review

Migdal Insurance & Financial Holdings sold out of Takeda Pharmaceutical (TAK) in Q1 2022, closing a stake of 3,121 shares — an estimated $42K sold.

Migdal Insurance & Financial Holdings first reported a position in TAK in Q3 2021 and held it in 2 quarters. The position peaked at $123K in Q3 2021. 288 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

  • Migdal Insurance & Financial Holdings reported no remaining Takeda Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 3,121 Takeda Pharmaceutical shares in Q1 2022, an estimated $42K.
  • Migdal Insurance & Financial Holdings first reported a position in Takeda Pharmaceutical in Q3 2021 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Takeda Pharmaceutical position peaked at $123K in Q3 2021.
  • 288 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.